| 纯度 | >85%SDS-PAGE. |
| 种属 | Human |
| 靶点 | DTNBP1 |
| Uniprot No | Q96EV8 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-351aa |
| 氨基酸序列 | MLETLRERLL SVQQDFTSGL KTLSDKSREA KVKSKPRTVP FLPKYSAGLE LLSRYEDTWA ALHRRAKDCA SAGELVDSEV VMLSAHWEKK KTSLVELQEQ LQQLPALIAD LESMTANLTH LEASFEEVEN NLLHLEDLCG QCELERCKHM QSQQLENYKK NKRKELETFK AELDAEHAQK VLEMEHTQQM KLKERQKFFE EAFQQDMEQY LSTGYLQIAE RREPIGSMSS MEVNVDMLEQ MDLMDISDQE ALDVFLNSGG EENTVLSPAL GPESSTCQNE ITLQVPNPSE LRAKPPSSSS TCTDSATRDI SEGGESPVVQ SDEEEVQVDT ALATSHTDRE ATPDGGEDSD S |
| 预测分子量 | kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
1. **《Dysbindin (DTNBP1) Expression in Neural Cells》** - 作者：Talukder, H. 等;摘要：该研究通过重组DTNBP1蛋白在大肠杆菌中的表达与纯化，分析了其与突触小泡相关蛋白的相互作用，证实其在神经细胞内的功能调控机制。
2. **《DTNBP1. a risk gene for schizophrenia, regulates synaptic vesicle assembly》** - 作者：Kumamoto, N. 等;摘要：利用重组DTNBP1蛋白进行体外结合实验，揭示其参与突触小泡组装的关键作用，并发现特定突变导致蛋白功能异常。
3. **《Genetic and functional analysis of the dystrobrevin-binding protein 1 (DTNBP1) in schizophrenia》** - 作者：Straub, R.E. 等;摘要：研究通过重组DTNBP1验证其与dystrobrevin的结合能力，探讨基因突变对蛋白互作及精神分裂症病理的影响。
4. **《Reduced DTNBP1 expression alters neuronal development and perturbs glutamate transmission》** - 作者：Weickert, C.S. 等;摘要：采用重组DTNBP1蛋白模型，证明其表达水平下降导致神经元发育异常及谷氨酸能突触传递缺陷，关联精神疾病机制。
(注：以上文献信息为示例性概括，实际文献需通过学术数据库查询确认。)
**Background of DTNBP1 Recombinant Protein**
DTNBP1 (dystrobrevin-binding protein 1), also known as dysbindin, is a protein encoded by the DTNBP1 gene, which has been extensively studied for its role in neurodevelopmental and psychiatric disorders, particularly schizophrenia. The gene is located on chromosome 6p22.3 and is highly expressed in brain regions critical for cognition and emotion, such as the hippocampus and prefrontal cortex. Dysbindin functions as a component of the BLOC-1 (biogenesis of lysosome-related organelles complex 1), influencing synaptic vesicle trafficking, neurotransmitter release, and synaptic plasticity. Reduced dysbindin levels have been linked to synaptic dysfunction and altered glutamatergic and dopaminergic signaling, contributing to the pathophysiology of schizophrenia.
Recombinant DTNBP1 protein is produced in vitro using expression systems (e.g., *E. coli*, mammalian cells*) to enable functional studies. Its recombinant form retains key structural domains, including coiled-coil motifs critical for protein-protein interactions, allowing researchers to investigate its binding partners (e.g., dystrobrevins, SNARE proteins) and molecular mechanisms in disease models. Purification methods often involve affinity tags (e.g., His-tag) for high yield and specificity.
Research applications include elucidating dysbindin's role in synaptic architecture, vesicle dynamics, and intracellular signaling. DTNBP1 recombinant protein is also used to explore therapeutic strategies targeting synaptic deficits or to validate genetic variants associated with neuropsychiatric disorders. Its study bridges genetic insights with cellular pathways, offering potential for biomarker discovery or novel treatments.
×
